Showing results (91-100 of 96) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
The Lancet. Oncology|January 4, 2015
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trialMohammed Z H Farooqui, Janet Valdez, Sabrina Martyr, et al.Leukemia & Lymphoma|March 3, 2021
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 studySanjal Desai, Clifton Mo, Erika M Gaglione, et al.Blood|February 28, 2018
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 studyInhye E Ahn, Mohammed Z H Farooqui, Xin Tian, et al.The Journal of Experimental Medicine|January 6, 2018
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Dania Benedetti, Sarah E M Herman, et al.Cancer Cell|May 26, 2012
Tetraspanin CD37 directly mediates transduction of survival and apoptotic signalsRosa Lapalombella, Yuh-Ying Yeh, Liwen Wang, et al.Cancer Cell|February 5, 2019
A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm DeletionShanye Yin, Rutendo G Gambe, Jing Sun, et al.Pageof 10